BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Hepatitis C virus
1
Cellular factors involved in the hepatitis C virus life cycle
7/26/2021 11:20:59 AM | Browse: 13 | Download: 28
2
Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use
6/18/2021 5:06:16 AM | Browse: 20 | Download: 26
3
Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched
5/27/2021 9:41:33 AM | Browse: 43 | Download: 51
4
Cascade of care for children and adolescents with chronic hepatitis C
3/25/2021 11:42:15 AM | Browse: 68 | Download: 44
5
Genotype 3-hepatitis C virus’ last line of defense
3/17/2021 6:19:34 AM | Browse: 76 | Download: 152
6
Histopathology and predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy
1/29/2021 7:57:41 AM | Browse: 90 | Download: 134
7
Human hepatitis viruses-associated cutaneous and systemic vasculitis
12/30/2020 1:59:10 PM | Browse: 132 | Download: 143
8
Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?
11/25/2020 2:44:05 PM | Browse: 136 | Download: 166
9
Associations of content and gene polymorphism of macrophage inhibitory factor-1 and chronic hepatitis C virus infection
11/6/2020 7:36:12 AM | Browse: 127 | Download: 328
10
Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations
10/24/2020 2:27:21 AM | Browse: 179 | Download: 295
11
Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history
10/24/2020 2:27:20 AM | Browse: 146 | Download: 162
12
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
10/14/2020 11:33:23 AM | Browse: 132 | Download: 251
13
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over
9/21/2020 4:02:08 PM | Browse: 137 | Download: 226
14
Liver transplantation and aging
9/16/2020 1:57:57 PM | Browse: 196 | Download: 210
15
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 171 | Download: 272
16
Accelerating the elimination of hepatitis C in Kuwait: An expert opinion
8/14/2020 12:33:31 PM | Browse: 179 | Download: 203
17
Facial and bilateral lower extremity edema due to drug-drug interactions in a patient with hepatitis C virus infection and benign prostate hypertrophy: A case report
8/6/2020 9:52:06 AM | Browse: 195 | Download: 290
18
M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
6/6/2020 2:43:56 PM | Browse: 303 | Download: 311
19
Pathological characterization of occult hepatitis B virus infection in hepatitis C virus-associated or non-alcoholic steatohepatitis-related hepatocellular carcinoma
4/28/2020 11:19:00 AM | Browse: 262 | Download: 277
20
Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma
4/7/2020 2:46:34 PM | Browse: 308 | Download: 438
21
Successful liver transplantation for acute sickle cell intrahepatic cholestasis: A case report and review of the literature
3/24/2020 5:16:35 AM | Browse: 271 | Download: 296
22
Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms
12/28/2019 9:29:28 AM | Browse: 295 | Download: 554
23
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study
10/28/2019 11:23:12 AM | Browse: 371 | Download: 589
24
Exploring the hepatitis C virus genome using single molecule real-time sequencing
8/28/2019 12:23:27 PM | Browse: 376 | Download: 326
25
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
8/7/2019 7:09:17 AM | Browse: 406 | Download: 516
26
Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions
8/7/2019 7:09:17 AM | Browse: 430 | Download: 443
27
Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals
6/6/2019 5:44:00 PM | Browse: 393 | Download: 550
28
Management of betablocked patients after sustained virological response in hepatitis C cirrhosis
6/6/2019 8:31:40 AM | Browse: 375 | Download: 600
29
Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus co-infection in human immunodeficiency virus infected individuals
5/27/2019 8:24:36 AM | Browse: 472 | Download: 307
30
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus
3/20/2019 5:32:10 AM | Browse: 518 | Download: 617
31
Necrolytic acral erythema in a human immunodeficiency virus/hepatitis C virus coinfected patient: A case report
2/26/2019 11:29:06 AM | Browse: 455 | Download: 475
32
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
1/26/2019 11:40:14 AM | Browse: 500 | Download: 477
33
Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
1/7/2019 10:39:41 AM | Browse: 439 | Download: 477
34
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
12/27/2018 9:28:07 AM | Browse: 413 | Download: 467
35
Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions
12/6/2018 1:35:45 PM | Browse: 564 | Download: 537
36
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
11/27/2018 1:56:41 PM | Browse: 485 | Download: 669
37
Mononuclear phagocyte system in hepatitis C virus infection
11/27/2018 5:55:53 AM | Browse: 416 | Download: 352
38
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
11/7/2018 2:30:08 AM | Browse: 465 | Download: 490
39
Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
10/26/2018 11:38:21 AM | Browse: 374 | Download: 515
40
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
10/12/2018 5:32:21 AM | Browse: 638 | Download: 469
41
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
9/27/2018 9:38:46 AM | Browse: 535 | Download: 582
42
Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
9/27/2018 9:38:46 AM | Browse: 429 | Download: 419
43
Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study
9/14/2018 5:53:04 AM | Browse: 468 | Download: 384
44
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 568 | Download: 437
45
Form confers function: Case of the 3’X region of the hepatitis C virus genome
8/13/2018 7:45:11 AM | Browse: 417 | Download: 366
46
Hepatitis C and renal transplantation in era of new antiviral agents
8/9/2018 8:05:57 AM | Browse: 464 | Download: 421
47
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 641 | Download: 502
48
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
6/26/2018 12:26:34 AM | Browse: 558 | Download: 498
49
Hepatitis C virus infection in children in the era of direct-acting antiviral
6/26/2018 12:26:34 AM | Browse: 683 | Download: 494
50
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM | Browse: 666 | Download: 706
Write to the Help Desk
© 2004-2021 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345